These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7163641)

  • 1. Noneffect of rifampin on theophylline disposition in rabbits.
    Self TH; Self MM; Worden JP; Taylor WS; Straughn AB
    Res Commun Chem Pathol Pharmacol; 1982 Dec; 38(3):505-8. PubMed ID: 7163641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of rifampin on theophylline kinetics.
    Boyce EG; Dukes GE; Rollins DE; Sudds TW
    J Clin Pharmacol; 1986; 26(8):696-9. PubMed ID: 3793963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rifampin on theophylline disposition.
    Straughn AB; Henderson RP; Lieberman PL; Self TH
    Ther Drug Monit; 1984; 6(2):153-6. PubMed ID: 6740733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tetracycline hydrochloride on theophylline kinetics.
    Mathis JW; Prince RA; Weinberger MM; McElnay JC
    Clin Pharm; 1982; 1(5):446-8. PubMed ID: 7184676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rifampin on the pharmacokinetics and pharmacodynamics of gliclazide.
    Park JY; Kim KA; Park PW; Park CW; Shin JG
    Clin Pharmacol Ther; 2003 Oct; 74(4):334-40. PubMed ID: 14534520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the modulation of P-glycoprotein (P-gp) on the intraocular disposition of its substrate in rabbits.
    Senthilkumari S; Velpandian T; Biswas NR; Saxena R; Ghose S
    Curr Eye Res; 2008 Apr; 33(4):333-43. PubMed ID: 18398708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Chiou method for determining theophylline dosages.
    Johnson MH; Burkle WS
    Clin Pharm; 1984; 3(2):174-8. PubMed ID: 6723223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
    Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
    Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theophylline elimination in the pregnant and fetal rabbit.
    Brashear RE; Veng-Pedersen P; Rhodes ML; Smith CN
    J Lab Clin Med; 1982 Jul; 100(1):15-25. PubMed ID: 7086267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rifampicin administration on theophylline pharmacokinetics in humans.
    Powell-Jackson PR; Jamieson AP; Gray BJ; Moxham J; Williams R
    Am Rev Respir Dis; 1985 Jun; 131(6):939-40. PubMed ID: 4003946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of rifampin administration on the disposition of fexofenadine.
    Hamman MA; Bruce MA; Haehner-Daniels BD; Hall SD
    Clin Pharmacol Ther; 2001 Mar; 69(3):114-21. PubMed ID: 11240975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue disposition of azithromycin after intravenous and intramuscular administration to rabbits.
    Cárceles CM; Fernández-Varón E; Marín P; Escudero E
    Vet J; 2007 Jul; 174(1):154-9. PubMed ID: 16904354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biopharmaceutical evaluation of aminophylline suppositories. I. Pharmacological parameters of theophylline from aminophylline suppositories with normal and prolonged time of total deformation].
    Masiakowski J; Cieszyński T; Dyderski S; Perz A
    Acta Pol Pharm; 1984; 41(1):99-104. PubMed ID: 6496143
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of cimetidine on the pharmacokinetics of theophylline.
    Schwartz JI; Bachmann KA; Bond LW; Mahajan VK
    Clin Pharm; 1982; 1(6):534-8. PubMed ID: 7185539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in hepatic induction and inhibition of theophylline pharmacokinetics and metabolism.
    Jennings TS; Nafziger AN; Davidson L; Bertino JS
    J Lab Clin Med; 1993 Aug; 122(2):208-16. PubMed ID: 8340707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in the pharmacokinetics of theophylline during estrus in rats].
    Bruguerolle B
    Pathol Biol (Paris); 1987 Feb; 35(2):181-3. PubMed ID: 3550629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea.
    Ahn HW; Shin WG; Park KJ; Suh OK; Choi JH
    Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):105-13. PubMed ID: 10850374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of rifampin, an inducer of CYP3A and P-glycoprotein, on the pharmacokinetics of risperidone.
    Kim KA; Park PW; Liu KH; Kim KB; Lee HJ; Shin JG; Park JY
    J Clin Pharmacol; 2008 Jan; 48(1):66-72. PubMed ID: 18094221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.